Salvage mFOLFOX in BTC After Failure of Gemcitabine
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of mFOLFOX (5-fluorouracil,
leucovorin, oxaliplatin)as salvage therapy in patients with unresectable biliary tract cancer
who had failed gemcitabine.
Phase:
Phase 2
Details
Lead Sponsor:
Chung-Ang University
Collaborators:
Dong-A University Hospital Gyeongsang National University Hospital Samsung Medical Center